IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

ANI Pharmaceuticals Inc

CUSIP: 00182CAC7 | FRANKFURT | 40 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Absolute Investment Advisers, LLC11,723,000
1.3% of portfolio›$13.7M
Citigroup Inc5,480,000
0.0% of portfolio›$6.4M
Jefferies Financial Group Inc.3,760,000
0.0% of portfolio›$4.4M
Bank of New York Mellon Corp650,000
0.0% of portfolio›$765.7K
Alken Asset Management Ltd2,250
0.0% of portfolio›$2.6K
StyleTurnoverLocationFiled
Absolute Investment Advisers, LLC
11,723,000$13.7M1.3%YieldHighRosemary Beach, FL2026-10-21
Citigroup Inc
5,480,000$6.4M0.0%CoreMediumNew York, NY2026-11-04
Jefferies Financial Group Inc.
3,760,000$4.4M0.0%CoreVery HighNew York, NY2026-11-05
Bank of New York Mellon Corp
650,000$765.7K0.0%CoreLowNew York, NY2026-11-05
Alken Asset Management Ltd
2,250$2.6K0.0%CoreMediumLondon, United Kingdom2026-10-20